I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Phospholipase C gamma 1 (PLCG1) R707Q mutation is counterse..:
Prenen, Hans
;
Smeets, Dominiek
;
Mazzone, Massimiliano
...
Oncotarget. 6 (2015) 34 - p. 36418-36425 , 2015
Link:
https://doi.org/10.18632/oncotarget.5503
RT Journal T1
Phospholipase C gamma 1 (PLCG1) R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma
UL https://suche.suub.uni-bremen.de/peid=cr-10.18632_oncotarget.5503&Exemplar=1&LAN=DE A1 Prenen, Hans A1 Smeets, Dominiek A1 Mazzone, Massimiliano A1 Lambrechts, Diether A1 Sagaert, Xavier A1 Sciot, Raf A1 Debiec-Rychter, Maria PB Impact Journals, LLC YR 2015 SN 1949-2553 JF Oncotarget VO 6 IS 34 SP 36418 OP 36425 LK http://dx.doi.org/https://doi.org/10.18632/oncotarget.5503 DO https://doi.org/10.18632/oncotarget.5503 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)